Viveka Roychowdhury, Author at Express Pharma

N-FIS was developed to address a critical challenge in healthcare—needle phobia

US tariffs, IP issues threaten patient access

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Balancing MAGA and MIGA

India is rising from a CDMO perspective when it comes to biologics

Trumping the Budget blues?

India’s biopharma industry needs to become a little bit more ambitious

Will Epygen’s biosimilars bets pay off?

2025: A year of stricter rules, course corrections?

Eco-conscious packaging: A strategic opportunity